CoChat

Fluoxetine treatment promotes functional recovery in a rat model of cervical spinal cord injury

Open access

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Abstract

Spinal cord injury (SCI) is a severe condition leading to enduring motor deficits. When lesions are incomplete, promoting spinal cord plasticity might be a useful strategy to elicit functional recovery. Here we investigated whether long-term fluoxetine administration in the drinking water, a treatment recently demonstrated to optimize brain plasticity in several pathological conditions, promotes motor recovery in rats that received a C4 dorsal funiculus crush. We show that fluoxetine administration markedly improved motor functions compared to controls in several behavioral paradigms. The improved functional effects correlated positively with significant sprouting of intact corticospinal fibers and a modulation of the excitation/inhibition balance. Our results suggest a potential application of fluoxetine treatment as a non invasive therapeutic strategy for SCI-associated neuropathologies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep02217

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Fluoxetine induces recovery of motor functions after SCI. (a, b) Staircase. After SCI, all rats lost grasping ability. Starting from the 2nd week, FLX rats began to retrieve significantly more pellets and showed a greater accuracy than CTR-inj. (c, d) Horizontal ladder. After SCI, the number of footslips was significantly increased in all groups. Starting from the 4th week, FLX rats showed a better performance than CTR-inj. The performance of CTR-sham rats did not change throughout the testing period. Box-whisker plot: the horizontal lines in the box denote the 25th, 50th (median), and 75th percentile values; the small square inside the box represents the mean; error bars denote the 5th and 95th percentile values. X represents max and min values. Curves: error bars represent SEM. Symbols indicate statistical difference.
Figure 1 Fluoxetine induces recovery of motor functions after SCI. (a, b) Staircase. After SCI, all rats lost grasping ability. Starting from the 2nd week, FLX rats began to retrieve significantly more pellets and showed a greater accuracy than CTR-inj. (c, d) Horizontal ladder. After SCI, the number of footslips was significantly increased in all groups. Starting from the 4th week, FLX rats showed a better performance than CTR-inj. The performance of CTR-sham rats did not change throughout the testing period. Box-whisker plot: the horizontal lines in the box denote the 25th, 50th (median), and 75th percentile values; the small square inside the box represents the mean; error bars denote the 5th and 95th percentile values. X represents max and min values. Curves: error bars represent SEM. Symbols indicate statistical difference.CC BY-NC-SA · PubMed Central
Figure 2 Faster recovery of gait coordination in FLX rats. (a) Typical footprints of animal walking 2 weeks after SCI. Gray: forepaw footprints; Black: hindpaw footprints (b) Gait analysis. After SCI, FLX rats showed a marked recovery of coordination compared to CTR-inj at the 3rd and 5th testing week. The performance of CTR-sham rats did not change throughout the testing period. Error bars represent SEM. Symbols indicate statistical difference.
Figure 2 Faster recovery of gait coordination in FLX rats. (a) Typical footprints of animal walking 2 weeks after SCI. Gray: forepaw footprints; Black: hindpaw footprints (b) Gait analysis. After SCI, FLX rats showed a marked recovery of coordination compared to CTR-inj at the 3rd and 5th testing week. The performance of CTR-sham rats did not change throughout the testing period. Error bars represent SEM. Symbols indicate statistical difference.CC BY-NC-SA · PubMed Central
Figure 3 Fluoxetine increases compensatory sprouting after SCI. (a) Diagram of BDA injections in the sensorimotor cortex. The position of SCI at C4 level is also indicated. (b) Representative pictures of sagittal spinal cord sections at C4 level of CTR-inj (left) and FLX treated (right) rats. Stars indicate lesion cavity. Arrows indicate traced sprouting CST fibers. Scale bar: 50 μm. (c) Quantification of sprouting fibers in the ventral grey matter at 0.5, 1.5, 2.5, 3.5, 4.5 mm from the lesion center, normalized on total counts at medulla oblongata level (100%). FLX rats showed more sprouting fibers at 1.5 and 4.5 mm caudal to the lesion than CTR-inj. Error bars represent SEM. Asterisks indicate statistical significance.
Figure 3 Fluoxetine increases compensatory sprouting after SCI. (a) Diagram of BDA injections in the sensorimotor cortex. The position of SCI at C4 level is also indicated. (b) Representative pictures of sagittal spinal cord sections at C4 level of CTR-inj (left) and FLX treated (right) rats. Stars indicate lesion cavity. Arrows indicate traced sprouting CST fibers. Scale bar: 50 μm. (c) Quantification of sprouting fibers in the ventral grey matter at 0.5, 1.5, 2.5, 3.5, 4.5 mm from the lesion center, normalized on total counts at medulla oblongata level (100%). FLX rats showed more sprouting fibers at 1.5 and 4.5 mm caudal to the lesion than CTR-inj. Error bars represent SEM. Asterisks indicate statistical significance.CC BY-NC-SA · PubMed Central
Figure 4 Fluoxetine increases the excitation/inhibition ratio in the motor cortex and the spinal cord. (a) Representative Western blot from control or fluoxetine-treated rat motor cortex (left) and spinal cord (right). Please note that cropped blots are shown (For full length blots, see Supplementary Information, Fig S1–S2). (b) Schematic diagram showing the synaptosome technique. (c, d) Quantification of the expression levels of the vesicular transporter proteins for glutamate and GABA (vGluT-1 and vGAT, respectively) by Western blot analysis, and of GABA and glutamate released after a pulse of KCl (15 mM) by synaptosomes in superfusion. Both the vGluT-1/vGAT expression ratio and the Glu/GABA stimulus-evoked overflow ratio were significantly increased after three weeks of fluoxetine treatment, either in the motor cortex and in the spinal cord. Error bars indicate SEM. Asterisks indicate statistical significance.
Figure 4 Fluoxetine increases the excitation/inhibition ratio in the motor cortex and the spinal cord. (a) Representative Western blot from control or fluoxetine-treated rat motor cortex (left) and spinal cord (right). Please note that cropped blots are shown (For full length blots, see Supplementary Information, Fig S1–S2). (b) Schematic diagram showing the synaptosome technique. (c, d) Quantification of the expression levels of the vesicular transporter proteins for glutamate and GABA (vGluT-1 and vGAT, respectively) by Western blot analysis, and of GABA and glutamate released after a pulse of KCl (15 mM) by synaptosomes in superfusion. Both the vGluT-1/vGAT expression ratio and the Glu/GABA stimulus-evoked overflow ratio were significantly increased after three weeks of fluoxetine treatment, either in the motor cortex and in the spinal cord. Error bars indicate SEM. Asterisks indicate statistical significance.CC BY-NC-SA · PubMed Central
Figure 5 Spinal cord injury. (a) Histological sagittal sections of CTR-inj (left) and FLX (right) cervical spinal cord. The star indicates the lesion cavity. (b) Quantification of lesion size in CTR-inj and FLX rats as the percentage of max transverse width of the spinal cord. There is no statistical difference between the two groups. Box-whisker plot: the horizontal lines in the box denote the 25th, 50th (median), and 75th percentile values; the small square inside the box represents the mean; error bars denote the 5th and 95th percentile values. X represents max and min values. Scale bar: 1 mm. Abbreviations: D, dorsal; V, ventral; R, rostral; C, caudal.
Figure 5 Spinal cord injury. (a) Histological sagittal sections of CTR-inj (left) and FLX (right) cervical spinal cord. The star indicates the lesion cavity. (b) Quantification of lesion size in CTR-inj and FLX rats as the percentage of max transverse width of the spinal cord. There is no statistical difference between the two groups. Box-whisker plot: the horizontal lines in the box denote the 25th, 50th (median), and 75th percentile values; the small square inside the box represents the mean; error bars denote the 5th and 95th percentile values. X represents max and min values. Scale bar: 1 mm. Abbreviations: D, dorsal; V, ventral; R, rostral; C, caudal.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

Metadata

Authors
Scali, M., Begenisic, T., Mainardi, M., Milanese, M., Bonifacino, T., Bonanno, G., Sale, A., & Maffei, L.
Affiliations
  • Neuroscience Institute (IT)
  • Scuola Normale Superiore (IT)
  • University of Genoa (IT)
Corresponding author
Sale, Alessandro
Venue
Scientific Reports
Published
2013-07-17
Volume
3
Issue
1
Pages
2217-2217
ISSN
2045-2322 (ISSN-L)
OpenAlex
W1999173606
Cited by
25
References
30
Citations by year
2025: 3 · 2024: 1 · 2023: 1 · 2021: 4 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 1
FWCI
1.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
  • Scuola Normale Superiore di Pisa (submittedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Spinal Cord Injury Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
  • Health Sciences › Medicine › Rehabilitation › Stroke Rehabilitation and Recovery
Keywords
fluoxetine, spinal cord injury, cervical spinal cord, motor recovery, excitation-inhibition balance, spinal cord plasticity, long-term drug administration, functional recovery
MeSH terms
Animals, Disease Models, Animal, Fluoxetine, Gait, Male, Motor Activity, Motor Cortex, Neuronal Plasticity, Psychomotor Performance, Spinal Cord, Spinal Cord Injuries, Time Factors, Selective Serotonin Reuptake Inhibitors, Recovery of Function, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.